COOK MEDICAL’s Spectrum antimicrobial-impregnated central venous catheters (CVC) are designed specifically to reduce the likelihood of a catheter-related bloodstream infection (CRBSI).
The CVC’s combination of minocycline and rifampin has proven to be an effective mixture so far in preventing CRBSIs while simultaneously avoiding antibiotic resistance. Minocycline and rifampin work synergistically to provide broadspectrum protection against grampositive, gram-negative and fungal organisms in both short- and long-term use. Unlike most systemic antibiotics, this combination can penetrate the infectious biofilm that forms on all indwelling catheters. Research shows conclusively that use of Spectrum catheters does not promote the growth of antibioticresistant strains of bacteria in patients. In another study published in the New England Journal of Medicine, the use of CVCs impregnated with minocycline and rifampin proved to reduce the incidence of CRBSIs to nearly zero.
